The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support.

Market Growth Overview :

The global injection pen market is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period.

Preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market during the forecast period to a certain extent. For instance, in emerging countries such as China and India, no coverage is provided for the home medical devices such as injection pens, thus increasing the out-of-pocket expenditure by patients.

Download PDF Brochure - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42342539

Scope of the Report:

The research report categorizes the market into the following segments and subsegments:

Injection Pen Market, by Type

Disposable injection pens
Reusable injection pens

Injection Pen Market, by End Users

Home care
Hospital & clinics

Injection Pen Market, by Therapy

Diabetes
Insulin
GLP-1
Growth hormone therapy
Fertility
Osteoporosis
Other therapies (multiple sclerosis, cardiovascular diseases, migraines, rheumatoid arthritis, obesity, Crohn's disease, and cancer)

Injection Pen Market, by Region

North America
Europe
Asia Pacific
Rest of the World

Request for Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=42342539

Segments : 

The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented into disposable and reusable injection pens.

The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the benefits disposable pens offer, such as portability, ease of use, and low possibility of infection.

Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular diseases, rheumatoid arthritis, and migraine).

The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the large diabetic population across the globe and the favorable reimbursement scenario for diabetes treatments in developed countries.

Geographical Region Covered : 

Geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017.

The large share of this region can be attributed to the rising prevalence of diabetes, favorable reimbursement scenario, and the increasing number of awareness programs in this region.

Inquiry before buying report on Injection Pen Market -
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=42342539